

Commodity investor Commoditrade narrowed full-year losses to $14.7m from $40.9m in 2008, although revenue sank to $20.1m from $31.1m despite an improv...


Speciality pharmaceutical company ProStrakan's New Drug Application (NDA) filing for Abstral has been accepted for review by the US Food and Drug Admi...